Breakpoint Therapeutics
PrivateLast Round
Series A
Extension
Oct 18, 2021
Total Funding Raised
$33.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Breakpoint Therapeutics operates in Healthcare & Life Sciences and is based in Hamburg. Its latest recorded funding round was a Series A Extension round in October 2021.
Breakpoint Therapeutics is a biotechnology company that discovers and develops anti-cancer drugs targeting DNA damage response mechanisms in cancer cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Breakpoint Therapeutics Comparables
Compare Breakpoint Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FoRx Therapeutics | 86% | |
| CV6 Therapeutics | 84% | |
| SynRx Therapeutics | 84% |
For institutional investors. Book with your work email.
Breakpoint Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 18, 2021 | ||||
| Series A | Jul 8, 2019 |
For institutional investors. Book with your work email.
Breakpoint Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiho Ventures | Series A |
| BVF Partners L.P. | Series A Extension |
| Medicxi | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 732% MoM, from 99 to 824.
- May 15, 2026
Monthly visitors grew 315% MoM, from 445 to 1.8K.
For institutional investors. Book with your work email.
Breakpoint Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Breakpoint Therapeutics's valuation, stock price, and market status.
Is Breakpoint Therapeutics a public or private company?
Breakpoint Therapeutics is a private company.
What is the current stock price of Breakpoint Therapeutics?
Breakpoint Therapeutics is a private company, so its shares have no public market price. Caplight tracks Breakpoint Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Breakpoint Therapeutics worth (valuation)?
Valuation information for Breakpoint Therapeutics is not publicly available.
Can I buy Breakpoint Therapeutics stock?
Breakpoint Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Breakpoint Therapeutics's last funding round?
Breakpoint Therapeutics's most recent funding round was Series A Extension on October 18, 2021.
Who are the main investors in Breakpoint Therapeutics?
Key investors in Breakpoint Therapeutics include Medicxi.
Will Breakpoint Therapeutics IPO soon?
No public IPO plans have been announced for Breakpoint Therapeutics.
How can I track Breakpoint Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Breakpoint Therapeutics's shares on secondary markets.